Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Bergmann

Showing results (331-340 of 350) with videos related to

Pageof 35
Sort By:
Journal of Pediatric Hematology/Oncology|January 1, 1997
Factor IX inhibitors and anaphylaxis in hemophilia BI Warrier, B M Ewenstein, M A Koerper, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 24, 2016
Factor IX inhibitors and anaphylaxis in hemophilia BI Warrier, B M Ewenstein, M A Koerper, et al.
Cell Death and Differentiation|January 24, 2015
CD95 promotes metastatic spread via Sck in pancreatic ductal adenocarcinomaM Teodorczyk, S Kleber, D Wollny, et al.
Ebiomedicine|December 24, 2017
What Is the most Important for Elite Control: Genetic Background of Patient, Genetic Background of Partner, both or neither? Description of Complete Natural History within a Couple of MSMM Bendenoun, A Samri, V Avettand-Fènoël, et al.
Hepatology (Baltimore, Md.)|October 13, 2010
Antiviral activity of narlaprevir combined with ritonavir and pegylated interferon in chronic hepatitis C patientsJoep de Bruijne, Jilling F Bergmann, Henk W Reesink, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 9, 2007
Gamma-glutamyltransferase and rapid virological response as predictors of successful treatment with experimental or standard peginterferon-alpha-2b in chronic hepatitis C non-respondersJilling F Bergmann, Jan M Vrolijk, Peter van der Schaar, et al.
Antiviral Therapy|August 17, 2010
Safety and antiviral activity of JTK-652: a novel HCV infection inhibitorJoep de Bruijne, Jilling F Bergmann, Christine J Weegink, et al.
Oncogene|August 6, 2013
Early epigenetic downregulation of WNK2 kinase during pancreatic ductal adenocarcinoma developmentC Dutruel, F Bergmann, I Rooman, et al.
Alimentary Pharmacology & Therapeutics|June 29, 2011
Randomised clinical trial: anti-viral activity of ANA773, an oral inducer of endogenous interferons acting via TLR7, in chronic HCVJ F Bergmann, J de Bruijne, D M Hotho, et al.
Seminars in Thrombosis and Hemostasis|November 25, 2000
Molecular biology and clinical manifestation of hereditary factor VII deficiencyF H Herrmann, K Wulff, K Auberger, et al.
Pageof 35

Showing results (331-340 of 350) with videos related to

Sort By:
Pageof 35
Journal of Pediatric Hematology/Oncology|January 1, 1997
Factor IX inhibitors and anaphylaxis in hemophilia BI Warrier, B M Ewenstein, M A Koerper, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 24, 2016
Factor IX inhibitors and anaphylaxis in hemophilia BI Warrier, B M Ewenstein, M A Koerper, et al.
Cell Death and Differentiation|January 24, 2015
CD95 promotes metastatic spread via Sck in pancreatic ductal adenocarcinomaM Teodorczyk, S Kleber, D Wollny, et al.
Ebiomedicine|December 24, 2017
What Is the most Important for Elite Control: Genetic Background of Patient, Genetic Background of Partner, both or neither? Description of Complete Natural History within a Couple of MSMM Bendenoun, A Samri, V Avettand-Fènoël, et al.
Hepatology (Baltimore, Md.)|October 13, 2010
Antiviral activity of narlaprevir combined with ritonavir and pegylated interferon in chronic hepatitis C patientsJoep de Bruijne, Jilling F Bergmann, Henk W Reesink, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 9, 2007
Gamma-glutamyltransferase and rapid virological response as predictors of successful treatment with experimental or standard peginterferon-alpha-2b in chronic hepatitis C non-respondersJilling F Bergmann, Jan M Vrolijk, Peter van der Schaar, et al.
Antiviral Therapy|August 17, 2010
Safety and antiviral activity of JTK-652: a novel HCV infection inhibitorJoep de Bruijne, Jilling F Bergmann, Christine J Weegink, et al.
Oncogene|August 6, 2013
Early epigenetic downregulation of WNK2 kinase during pancreatic ductal adenocarcinoma developmentC Dutruel, F Bergmann, I Rooman, et al.
Alimentary Pharmacology & Therapeutics|June 29, 2011
Randomised clinical trial: anti-viral activity of ANA773, an oral inducer of endogenous interferons acting via TLR7, in chronic HCVJ F Bergmann, J de Bruijne, D M Hotho, et al.
Seminars in Thrombosis and Hemostasis|November 25, 2000
Molecular biology and clinical manifestation of hereditary factor VII deficiencyF H Herrmann, K Wulff, K Auberger, et al.
Pageof 35